10 years ago, your company discovered an Intervention that would easily detect early stages ofbreast cancer. Since then, you have developed three intervention X, Y and Z that are alleffective in providing this benefit. You conduct a study that will now compare the cost ofproducing each of the interventions X, Y and Z, to find which will be most accessible to thepublic. This study is best known as:Evidence of benefit studyO Cost-effectiveness analysisCost-benefit analysisO Delay of benefits study

Answered: 10 years ago, your company discovered…

3-2-1 Code It

6th Edition

ISBN:9781337660549

Author:GREEN

Publisher:GREEN

Chapter19: Insurance And Reimbursement

Section: Chapter Questions

Problem 7MC

See similar textbooks

Similar questions

Recommend at least three communication methods which can be used for sharing the results of a cancer program evaluation with stakeholders and how you will communicate any future program improvements or adaptations
Which demographic groups have the highestincidence of lung/bronchus cancer (in terms ofrace and sex)? Would this group be a good targetmarket for CVS Caremark?
Now consider the use of Table 1 within the nursing research article. When reading research articles, many people will skip over the tables and figures. Why do you think the authors included it? Was it helpful? Why or why not? Note: I can't post the article but here's a paragraph where Table 1 is mentioned. RESULTS Patient selection and baseline characteristics Between 2010 and 2015, 132 women were diagnosed with ovarian cancer at the Diakonessenhuis. Four patients were excluded from further analysis because they were treated elsewhere. Therefore, 128 patients were included in this study. Baseline characteristics for patients aged
What is the significance of considering and incorporating health or healthcare disparities in program planning for cancer mortalities in health needs assenssment?
A new screening program was instituted in a certain country. The program used a screening test that is effective in detecting cancer Z at an early stage. Assume that there is an effective treatment for this type of cancer and, therefore, that the program results in a change in the usual course of the disease (decrease in death due to the cancer). Assume also that the rates noted are calculated in the quality of death certification of this disease. A. During the first year of this program will the incidence rate of cancer Z increase, decrease, or remain constant? B. During the first year of this program will the prevalence rate of cancer Z increase, decrease, or remain constant? C. During the first year of this program will the case-fatality rate of cancer Z increase, decrease, or remain constant? D. As a result of this program, will the mortality rate from cancer Z in the country increase, decrease, or remain constant?
Which of the following study types is considered the most reliable evidence for a nutritional or medical research claim? A) an intervention study such as a large-scale clinical trial B) a case study which clearly shows the relationship between a treatment and result C) an epidemiological study which clearly shows the relationship between two factors D) a laboratory study on rats which shows how a treatment affects the result
People with certain types of prostrate or breast cancer can opt to do for “active surveillance”, which consists of frequent monitoring with scans and biomarker measurements rather than undergoing through chemotherapy, surgery or radiation soon after diagnosis. What type of information would be helpful in deciding whether to follow “active surveillance” ? What type of biomarkers are used for prostrate and breast cancer? And how they are helpful.
A patient diagnosed with breast cancer who is in the endstages of her illness has been in the medical intensive careunit for 3 weeks. Her husband tells the nurse caring for thepatient that he and his wife often talked about the end of herlife and that she was very clear about not wanting aggressivetreatment that would merely prolong her dying. The nurseand husband both agree that this seems to be all that therapy is now doing for her. The nurse would suggest that the hus-band speak to his wife’s physician about which type of order? a. Comfort-measures-onlyb. Do-not-hospitalizec. Do-not-resuscitated. Slow-code-only
BENEFIT: advantages, good effects/impacts, profit COST: disadvantages, negative effects/impacts, drawbacks Scenario Benefits (List 3 possible benefits) Costs (List 3 possible costs) Assessment Which do you think is more equitable in its impact? (benefit or cost) Why? 1. Nanotechnology can provide alternatives to early detection of cancer cells, drug delivery, and injectable vaccines that to this day rely on healthcare professionals to administer. 2. Nanotechnology can be used to reduce pollutants in the environment such as radioactive wastes, oil spill, and propylene oxide, the raw material for making plastics. 3. Nanotechnology can be incorporated into solar panels to convert sunlight to electricity more efficiently and helps in cleaner production of alternative and renewable energy sources.
A lady who has been working as a nuclear medicine technician for 30 years is diagnosed with colon cancer. She is a nonsmoker and known of no exposure to other risk factors of colocancer. If the estimated excess relative risk of colon cancer in that lady is 0.11, their at the estimated probability of causation of colon cancer due to radiation in the lady?
The dose-response effect is best described as A. when the value of the response variable changes in a meaningful way with the dosage of the suspected cause. B. when all other possible causes are ruled out. C. when the suspected cause precedes the response variable. D. when similar studies produce similar results
We discussed the Donabedian model (resources, processes, outputs, outcomes and Impact) in relation to principles of value-based medicine. Can you explain the link between these two concepts?

SEE MORE QUESTIONS

Recommended textbooks for you

3-2-1 Code It

Biology

ISBN:

9781337660549

Author:

GREEN

Publisher:

Cengage

Comprehensive Medical Assisting: Administrative a…

Nursing

ISBN:

9781305964792

Author:

Wilburta Q. Lindh, Carol D. Tamparo, Barbara M. Dahl, Julie Morris, Cindy Correa

Publisher:

Cengage Learning

Understanding Health Insurance: A Guide to Billin…

Health & Nutrition

ISBN:

9781337679480

Author:

GREEN

Publisher:

Cengage

3-2-1 Code It

Biology

ISBN:

9781337660549

Author:

GREEN

Publisher:

Cengage

Comprehensive Medical Assisting: Administrative a…

Nursing

ISBN:

9781305964792

Author:

Wilburta Q. Lindh, Carol D. Tamparo, Barbara M. Dahl, Julie Morris, Cindy Correa

Publisher:

Cengage Learning

Understanding Health Insurance: A Guide to Billin…

Health & Nutrition

ISBN:

9781337679480

Author:

GREEN

Publisher:

Cengage

SEE MORE TEXTBOOKS